Business
Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells
Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells\nPR Newswire\nTEL AVIV, Israel, September 25, 2017\n\n\n\n\n \n\nTEL AVIV, Israel, September 25, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) today announced it has filed national phase patent applications for its 'System and Method for High Throughput Screening of Cancer Cells' in the United States, Europe, China, India, Brazil, Canada and Australia.\n\n \n\n\n\n\n \n \n\n \nThe company has filed the national phase applications after having received a favorable international patentability report from the PCT authorities regarding patent application PCT/IL2016/050471 finding all the claims innovative and inventive.\n\nThe proprietary technology patented relates to novel means of personalizing cannabis based treatments of cancer utilizing high throughput screening of biopsies and cell lines treated with pure or crude extracts. The screening enables the examination of a multitude of different cannabis compounds containing varied levels of cannabinoids such as THC, THCA, CBD, CBDA and their impact on the cancer cells. Since many cancer patients use natural cannabis as a palliative medicine to reduce pain, nausea and depression, the search for anticancer properties in the matrix of compounds may reveal and lead to better outcomes and lead to an integrated medicine, both palliative and anti-cancerous, which is natural, potent and with no side effects related to chemotherapy.\n\n\"Cannabics Pharmaceuticals intellectual property portfolio surpasses various methods of diagnostics and treatments that arise from the patients' genetics and biology and through tracking the treatment outcome,\" said Dr. Eyal Ballan, Chief Scientist of Cannabics Pharmaceuticals Inc. \"It is a well-established notion that the success in treating cancer is based o...